Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.

Arsenic-induced metabolic shift triggered by the loss of miR-199a-5p through Sp1-dependent DNA methylation.

He J, Liu W, Ge X, Wang GC, Desai V, Wang S, Mu W, Bhardwaj V, Seifert E, Liu LZ, Bhushan A, Peiper SC, Jiang BH.

Toxicol Appl Pharmacol. 2019 Sep 1;378:114606. doi: 10.1016/j.taap.2019.114606. Epub 2019 Jun 3.

PMID:
31170415
2.

Rapid Early Tumor Progression is Prognostic in Glioblastoma Patients.

Palmer JD, Bhamidipati D, Shukla G, Sharma D, Glass J, Kim L, Evans JJ, Judy K, Farrell C, Andrews DW, Wang ZW, Peiper SC, Werner-Wasik M, Shi W.

Am J Clin Oncol. 2019 May;42(5):481-486. doi: 10.1097/COC.0000000000000537.

PMID:
30973372
3.

Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer.

Liao L, Liu ZZ, Langbein L, Cai W, Cho EA, Na J, Niu X, Jiang W, Zhong Z, Cai WL, Jagannathan G, Dulaimi E, Testa JR, Uzzo RG, Wang Y, Stark GR, Sun J, Peiper S, Xu Y, Yan Q, Yang H.

Elife. 2018 Oct 25;7. pii: e37925. doi: 10.7554/eLife.37925.

4.

Prostate cancer sheds the αvβ3 integrin in vivo through exosomes.

Krishn SR, Singh A, Bowler N, Duffy AN, Friedman A, Fedele C, Kurtoglu S, Tripathi SK, Wang K, Hawkins A, Sayeed A, Goswami CP, Thakur ML, Iozzo RV, Peiper SC, Kelly WK, Languino LR.

Matrix Biol. 2019 Apr;77:41-57. doi: 10.1016/j.matbio.2018.08.004. Epub 2018 Aug 8.

5.

Endorepellin remodels the endothelial transcriptome toward a pro-autophagic and pro-mitophagic gene signature.

Neill T, Andreuzzi E, Wang ZX, Peiper SC, Mongiat M, Iozzo RV.

J Biol Chem. 2018 Aug 3;293(31):12137-12148. doi: 10.1074/jbc.RA118.002934. Epub 2018 Jun 19.

6.

The Future Is Today.

Peiper SC, Ehrlich GD.

Genet Test Mol Biomarkers. 2018 May;22(5):279-280. doi: 10.1089/gtmb.2018.0107. No abstract available.

PMID:
29791231
7.

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N, Freedman ML, Hamdy FC, Hoffman-Censits J, Hurwitz MD, Hyatt C, Isaacs WB, Kane CJ, Kantoff P, Karnes RJ, Karsh LI, Klein EA, Lin DW, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann MJ, Mark JR, McCue PA, Miner MM, Morgan T, Moul JW, Myers RE, Nielsen SM, Obeid E, Pavlovich CP, Peiper SC, Penson DF, Petrylak D, Pettaway CA, Pilarski R, Pinto PA, Poage W, Raj GV, Rebbeck TR, Robson ME, Rosenberg MT, Sandler H, Sartor O, Schaeffer E, Schwartz GF, Shahin MS, Shore ND, Shuch B, Soule HR, Tomlins SA, Trabulsi EJ, Uzzo R, Vander Griend DJ, Walsh PC, Weil CJ, Wender R, Gomella LG.

J Clin Oncol. 2018 Feb 1;36(4):414-424. doi: 10.1200/JCO.2017.74.1173. Epub 2017 Dec 13. Review.

8.

Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma.

Jiang W, Dulaimi E, Devarajan K, Parsons T, Wang Q, O'Neill R, Solomides C, Peiper SC, Testa JR, Uzzo R, Yang H.

Oncotarget. 2017 Jun 6;8(23):37423-37434. doi: 10.18632/oncotarget.16965.

9.

The perlecan-interacting growth factor progranulin regulates ubiquitination, sorting, and lysosomal degradation of sortilin.

Tanimoto R, Palladino C, Xu SQ, Buraschi S, Neill T, Gomella LG, Peiper SC, Belfiore A, Iozzo RV, Morrione A.

Matrix Biol. 2017 Dec;64:27-39. doi: 10.1016/j.matbio.2017.04.001. Epub 2017 Apr 20.

10.

Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling.

Shi ZM, Wang L, Shen H, Jiang CF, Ge X, Li DM, Wen YY, Sun HR, Pan MH, Li W, Shu YQ, Liu LZ, Peiper SC, He J, Jiang BH.

Oncogene. 2017 May 4;36(18):2577-2588. doi: 10.1038/onc.2016.414. Epub 2017 Feb 13.

11.

Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin.

Buraschi S, Xu SQ, Stefanello M, Moskalev I, Morcavallo A, Genua M, Tanimoto R, Birbe R, Peiper SC, Gomella LG, Belfiore A, Black PC, Iozzo RV, Morrione A.

Oncotarget. 2016 Jun 28;7(26):39980-39995. doi: 10.18632/oncotarget.9556.

12.

Immunohistochemistry Successfully Uncovers Intratumoral Heterogeneity and Widespread Co-Losses of Chromatin Regulators in Clear Cell Renal Cell Carcinoma.

Jiang W, Dulaimi E, Devarajan K, Parsons T, Wang Q, Liao L, Cho EA, O'Neill R, Solomides C, Peiper SC, Testa JR, Uzzo R, Yang H.

PLoS One. 2016 Oct 20;11(10):e0164554. doi: 10.1371/journal.pone.0164554. eCollection 2016.

13.
14.

Efficacy of DSP30-IL2/TPA for detection of cytogenetic abnormalities in chronic lymphocytic leukaemia/small lymphocytic lymphoma.

Holmes PJ, Peiper SC, Uppal GK, Gong JZ, Wang ZX, Bajaj R.

Int J Lab Hematol. 2016 Oct;38(5):483-9. doi: 10.1111/ijlh.12513. Epub 2016 Aug 27.

PMID:
27565124
15.

Identification of a novel metabolic-related mutation (IDH1) in metastatic pancreatic cancer.

Brody JR, Yabar CS, Zarei M, Bender J, Matrisian LM, Rahib L, Heartwell C, Mason K, Yeo CJ, Peiper SC, Jiang W, Varieur K, Madhavan S, Petricoin E 3rd, Fortuna D, Curtis M, Wang ZX, Pishvaian MJ, Winter JM.

Cancer Biol Ther. 2018 Apr 3;19(4):249-253. doi: 10.1080/15384047.2016.1210743. Epub 2018 Mar 6.

16.

A novel role for drebrin in regulating progranulin bioactivity in bladder cancer.

Xu SQ, Buraschi S, Morcavallo A, Genua M, Shirao T, Peiper SC, Gomella LG, Birbe R, Belfiore A, Iozzo RV, Morrione A.

Oncotarget. 2015 May 10;6(13):10825-39.

17.

Regulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression.

Xu Q, Liu LZ, Yin Y, He J, Li Q, Qian X, You Y, Lu Z, Peiper SC, Shu Y, Jiang BH.

Oncogene. 2015 Oct;34(43):5482-93. doi: 10.1038/onc.2015.6. Epub 2015 Feb 23.

PMID:
25703326
18.

The utility of BRAF V600E mutation-specific antibody VE1 for the diagnosis of hairy cell leukemia.

Uppal G, Ly V, Wang ZX, Bajaj R, Solomides CC, Banks PM, Medeiros LJ, Peiper SC, Gong JZ.

Am J Clin Pathol. 2015 Jan;143(1):120-5. doi: 10.1309/AJCPQLQ89VXTVWKN.

PMID:
25511150
19.

Validation of a next-generation-sequencing cancer panel for use in the clinical laboratory.

Simen BB, Yin L, Goswami CP, Davis KO, Bajaj R, Gong JZ, Peiper SC, Johnson ES, Wang ZX.

Arch Pathol Lab Med. 2015 Apr;139(4):508-17. doi: 10.5858/arpa.2013-0710-OA. Epub 2014 Oct 30.

PMID:
25356985
20.

Comparison of Chromogenic In Situ Hybridization and Fluorescence In Situ Hybridization for the Evaluation of MDM2 Amplification in Adipocytic Tumors.

Mardekian SK, Solomides CC, Gong JZ, Peiper SC, Wang ZX, Bajaj R.

J Clin Lab Anal. 2015 Nov;29(6):462-8. doi: 10.1002/jcla.21794. Epub 2014 Aug 17.

21.

Regulation of motor function and behavior by atypical chemokine receptor 1.

Schneider EH, Fowler SC, Lionakis MS, Swamydas M, Holmes G, Diaz V, Munasinghe J, Peiper SC, Gao JL, Murphy PM.

Behav Genet. 2014 Sep;44(5):498-515. doi: 10.1007/s10519-014-9665-7. Epub 2014 Jul 6.

22.

Primary central nervous system Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a clinicopathologic study of five cases.

Jamal SE, Li S, Bajaj R, Wang Z, Kenyon L, Glass J, Pang CS, Bhagavathi S, Peiper SC, Gong JZ.

Brain Tumor Pathol. 2014 Oct;31(4):265-73. doi: 10.1007/s10014-013-0173-x. Epub 2014 Jan 8.

PMID:
24399201
23.

Characterization of the receptor binding residues of kisspeptins by positional scanning using peptide photoaffinity probes.

Misu R, Oishi S, Setsuda S, Noguchi T, Kaneda M, Ohno H, Evans B, Navenot JM, Peiper SC, Fujii N.

Bioorg Med Chem Lett. 2013 May 1;23(9):2628-31. doi: 10.1016/j.bmcl.2013.02.098. Epub 2013 Mar 4.

PMID:
23522565
24.

Enhanced T cell lymphoma in NOD.Stat5b transgenic mice is caused by hyperactivation of Stat5b in CD8+ thymocytes.

Chen B, Yi B, Mao R, Liu H, Wang J, Sharma A, Peiper S, Leonard WJ, She JX.

PLoS One. 2013;8(2):e56600. doi: 10.1371/journal.pone.0056600. Epub 2013 Feb 14.

25.

MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis.

Solomides CC, Evans BJ, Navenot JM, Vadigepalli R, Peiper SC, Wang ZX.

Acta Cytol. 2012;56(6):645-54. doi: 10.1159/000343473. Epub 2012 Nov 24.

PMID:
23207443
26.

Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a/125b and DNA methylation.

He J, Xu Q, Jing Y, Agani F, Qian X, Carpenter R, Li Q, Wang XR, Peiper SS, Lu Z, Liu LZ, Jiang BH.

EMBO Rep. 2012 Dec;13(12):1116-22. doi: 10.1038/embor.2012.162. Epub 2012 Nov 13.

27.

Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model.

Buraschi S, Neill T, Owens RT, Iniguez LA, Purkins G, Vadigepalli R, Evans B, Schaefer L, Peiper SC, Wang ZX, Iozzo RV.

PLoS One. 2012;7(9):e45559. doi: 10.1371/journal.pone.0045559. Epub 2012 Sep 19.

28.

A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.

Xu Q, Jiang Y, Yin Y, Li Q, He J, Jing Y, Qi YT, Xu Q, Li W, Lu B, Peiper SS, Jiang BH, Liu LZ.

J Mol Cell Biol. 2013 Feb;5(1):3-13. doi: 10.1093/jmcb/mjs049. Epub 2012 Aug 29.

29.

Proline-rich tyrosine kinase 2 (Pyk2) regulates IGF-I-induced cell motility and invasion of urothelial carcinoma cells.

Genua M, Xu SQ, Buraschi S, Peiper SC, Gomella LG, Belfiore A, Iozzo RV, Morrione A.

PLoS One. 2012;7(6):e40148. doi: 10.1371/journal.pone.0040148. Epub 2012 Jun 28. Retraction in: PLoS One. 2019 Apr 18;14(4):e0215889.

30.

Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells.

Fiskus W, Hembruff SL, Rao R, Sharma P, Balusu R, Venkannagari S, Smith JE, Peth K, Peiper SC, Bhalla KN.

Breast Cancer Res Treat. 2012 Sep;135(2):433-44. doi: 10.1007/s10549-012-2171-9. Epub 2012 Jul 24.

PMID:
22825030
31.

Paradoxical downregulation of CXC chemokine receptor 4 induced by polyphemusin II-derived antagonists.

Masuda R, Oishi S, Tanahara N, Ohno H, Hirasawa A, Tsujimoto G, Yano Y, Matsuzaki K, Navenot JM, Peiper SC, Fujii N.

Bioconjug Chem. 2012 Jun 20;23(6):1259-65. doi: 10.1021/bc300084h. Epub 2012 May 9.

PMID:
22486464
32.

The metastasis suppressor KISS1 lacks antimetastatic activity in the C8161.9 xenograft model of melanoma.

Navenot JM, Evans B, Oishi S, Setsuda S, Fujii N, Peiper SC.

Melanoma Res. 2012 Apr;22(2):140-50. doi: 10.1097/CMR.0b013e328350fa07.

PMID:
22395416
33.

Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma.

Valsecchi ME, McDonald M, Brody JR, Hyslop T, Freydin B, Yeo CJ, Solomides C, Peiper SC, Witkiewicz AK.

Cancer. 2012 Jul 15;118(14):3484-93. doi: 10.1002/cncr.26661. Epub 2011 Nov 15.

34.

Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling.

Iozzo RV, Buraschi S, Genua M, Xu SQ, Solomides CC, Peiper SC, Gomella LG, Owens RC, Morrione A.

J Biol Chem. 2011 Oct 7;286(40):34712-21. doi: 10.1074/jbc.M111.262766. Epub 2011 Aug 12.

35.

Role and mechanism of arsenic in regulating angiogenesis.

Liu LZ, Jiang Y, Carpenter RL, Jing Y, Peiper SC, Jiang BH.

PLoS One. 2011;6(6):e20858. doi: 10.1371/journal.pone.0020858. Epub 2011 Jun 8.

36.

Chromosomal abnormalities in renal cell carcinoma variants detected by Urovysion fluorescence in situ hybridization on paraffin-embedded tissue.

Reid-Nicholson MD, Motiwala N, Drury SC, Peiper SC, Terris MK, Waller JL, Ramalingam P.

Ann Diagn Pathol. 2011 Feb;15(1):37-45. doi: 10.1016/j.anndiagpath.2010.07.011.

PMID:
21238914
37.

Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonists.

Mandawat A, Fiskus W, Buckley KM, Robbins K, Rao R, Balusu R, Navenot JM, Wang ZX, Ustun C, Chong DG, Atadja P, Fujii N, Peiper SC, Bhalla K.

Blood. 2010 Dec 9;116(24):5306-15. doi: 10.1182/blood-2010-05-284414. Epub 2010 Sep 1.

PMID:
20810927
38.

Distinct molecular signatures in pediatric infratentorial glioblastomas defined by aCGH.

Sharma S, Free A, Mei Y, Peiper SC, Wang Z, Cowell JK.

Exp Mol Pathol. 2010 Oct;89(2):169-74. doi: 10.1016/j.yexmp.2010.06.009. Epub 2010 Jul 16.

PMID:
20621092
39.

Fluorescent imaging of high-grade bladder cancer using a specific antagonist for chemokine receptor CXCR4.

Nishizawa K, Nishiyama H, Oishi S, Tanahara N, Kotani H, Mikami Y, Toda Y, Evans BJ, Peiper SC, Saito R, Watanabe J, Fujii N, Ogawa O.

Int J Cancer. 2010 Sep 1;127(5):1180-7. doi: 10.1002/ijc.25145.

40.

Structure-activity relationship study on artificial CXCR4 ligands possessing the cyclic pentapeptide scaffold: the exploration of amino acid residues of pentapeptides by substitutions of several aromatic amino acids.

Tanaka T, Nomura W, Narumi T, Esaka A, Oishi S, Ohashi N, Itotani K, Evans BJ, Wang ZX, Peiper SC, Fujii N, Tamamura H.

Org Biomol Chem. 2009 Sep 21;7(18):3805-9. doi: 10.1039/b908286g. Epub 2009 Jul 20.

PMID:
19707686
41.

Expression of CXCR4, a G-protein-coupled receptor for CXCL12 in yeast identification of new-generation inverse agonists.

Evans BJ, Wang Z, Broach JR, Oishi S, Fujii N, Peiper SC.

Methods Enzymol. 2009;460:399-412. doi: 10.1016/S0076-6879(09)05220-3.

PMID:
19446737
42.

Development of chemokine receptor CXCR4 antagonists using bio-mimetic strategy.

Tamamura H, Tanaka T, Tsutsumi H, Ohashi N, Hiramatsu K, Araki T, Ojida A, Hamachi I, Wang Z, Peiper SC, Trent JO, Ueda S, Oishi S, Fujii N.

Adv Exp Med Biol. 2009;611:145-6. No abstract available.

PMID:
19400132
43.

Near real-time immuno-optical sensor for diagnosing single point mutation: a model system: sensor for factor V Leiden diagnosis.

Kang KA, Ren Y, Sharma VR, Peiper SC.

Biosens Bioelectron. 2009 May 15;24(9):2785-90. doi: 10.1016/j.bios.2009.02.004. Epub 2009 Feb 20.

44.

Activation of Rho and Rho-associated kinase by GPR54 and KiSS1 metastasis suppressor gene product induces changes of cell morphology and contributes to apoptosis.

Navenot JM, Fujii N, Peiper SC.

Mol Pharmacol. 2009 Jun;75(6):1300-6. doi: 10.1124/mol.109.055095. Epub 2009 Mar 13.

PMID:
19286835
45.

KiSS1 metastasis suppressor gene product induces suppression of tyrosine kinase receptor signaling to Akt, tumor necrosis factor family ligand expression, and apoptosis.

Navenot JM, Fujii N, Peiper SC.

Mol Pharmacol. 2009 May;75(5):1074-83. doi: 10.1124/mol.108.054270. Epub 2009 Feb 6.

PMID:
19201817
46.

Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase.

Tomita K, Oishi S, Ohno H, Peiper SC, Fujii N.

J Med Chem. 2008 Dec 11;51(23):7645-9. doi: 10.1021/jm800930w.

PMID:
19007202
47.

The use of Urovysion fluorescence in situ hybridization in the diagnosis and surveillance of non-urothelial carcinoma of the bladder.

Reid-Nicholson MD, Ramalingam P, Adeagbo B, Cheng N, Peiper SC, Terris MK.

Mod Pathol. 2009 Jan;22(1):119-27. doi: 10.1038/modpathol.2008.179. Epub 2008 Oct 31.

48.

Physical association of GPR54 C-terminal with protein phosphatase 2A.

Evans BJ, Wang Z, Mobley L, Khosravi D, Fujii N, Navenot JM, Peiper SC.

Biochem Biophys Res Commun. 2008 Dec 26;377(4):1067-71. doi: 10.1016/j.bbrc.2008.10.108. Epub 2008 Oct 31.

PMID:
18977201
49.

Cotreatment with vorinostat enhances activity of MK-0457 (VX-680) against acute and chronic myelogenous leukemia cells.

Fiskus W, Wang Y, Joshi R, Rao R, Yang Y, Chen J, Kolhe R, Balusu R, Eaton K, Lee P, Ustun C, Jillella A, Buser CA, Peiper S, Bhalla K.

Clin Cancer Res. 2008 Oct 1;14(19):6106-15. doi: 10.1158/1078-0432.CCR-08-0721.

50.

Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor-resistant acute myeloid leukemia cells.

Fiskus W, Rao R, Fernandez P, Herger B, Yang Y, Chen J, Kolhe R, Mandawat A, Wang Y, Joshi R, Eaton K, Lee P, Atadja P, Peiper S, Bhalla K.

Blood. 2008 Oct 1;112(7):2896-905. doi: 10.1182/blood-2007-10-116319. Epub 2008 Jul 25.

PMID:
18660379

Supplemental Content

Loading ...
Support Center